Brain Dopamine – Clock Interactions Regulate Cardiometabolic Health in T2D
http://www.diabetesincontrol.com/brain-dopamine-clock-interactions-regulate-cardiometabolic-health-in-t2d/
Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
http://www.diabetesincontrol.com/brain-dopamine-clock-interactions-regulate-cardiometabolic-health-in-t2d/
https://www.wcir.org/
http://www.metabesity2019.com/
https://www.clevelandclinicmeded.com/live/courses/endo/
https://www.aace.com/chapters/new-england
https://www.endocrine.org/ceu
https://www.aace.com/chapters/carolinas
https://www.aace.com/chapters/texas
https://www.heartindiabetes.com
https://www.heartindiabetes.com